Emerging trends in the management of neuropathic pain.
Despite significant improvements in our ability to treat neuropathic pain, we are far from the situation of being able to guarantee pain relief. The next few years promise to see the introduction of novel pharmacologic entities that show potential in the field of neuropathic pain treatment. Allied to this will be the realization that some drugs originally released for nonpain indications in fact have an analgesic effect in neuropathic pain. Our treatment armamentarium will be further enhanced by the release of currently available agents with proven efficacy but in new formulations. However, not every product of our improved knowledge will manifest as a new drug treatment for neuropathic pain. Despite evidence of efficacy, some drugs will fail to reach commercialization due to the lack of investment in their clinical development.
McCleane
Gary
G
Rampark Pain Centre, 2 Rampark, Dromore Road, Lurgan, BT66 7JH, Northern Ireland, UK. gary@mccleane.freeserve.co.uk
D000700:Analgesics / Q000145:classification / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005104:Expert Testimony; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy*
D000700:Analgesics; D015507:Drugs, Investigational